ACAD Rises
ACADIA Pharmaceuticals shares are trading higher after the European Medicines Agency recommended market authorization for DAYBU
ACAD ACADIA Pharmaceuticals shares are trading higher after the company announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended the granting of a market authorization for DAYBU.